148 related articles for article (PubMed ID: 34982493)
1. Comparison of systemic and topical isotretinoin in the treatment of facial lichen planopilaris: A randomized controlled trial.
Saber M; Bahraminejad M; Fatemi Naeini F; Mohaghegh F; Faghihi G; Hosseini SM
J Cosmet Dermatol; 2022 Sep; 21(9):3896-3904. PubMed ID: 34982493
[TBL] [Abstract][Full Text] [Related]
2. Postmenopausal frontal fibrosing alopecia: a frontal variant of lichen planopilaris.
Kossard S; Lee MS; Wilkinson B
J Am Acad Dermatol; 1997 Jan; 36(1):59-66. PubMed ID: 8996262
[TBL] [Abstract][Full Text] [Related]
3. Oral isotretinoin combined with topical clobetasol 0.05% and tacrolimus 0.1% for the treatment of frontal fibrosing alopecia: a randomized controlled trial.
Mahmoudi H; Rostami A; Tavakolpour S; Nili A; Teimourpour A; Salehi Farid A; Abedini R; Amini M; Daneshpazhooh M
J Dermatolog Treat; 2022 Feb; 33(1):284-290. PubMed ID: 32238014
[TBL] [Abstract][Full Text] [Related]
4. Evaluating the combined efficacy of oral isotretinoin and topical tacrolimus versus oral finasteride and topical tacrolimus in frontal fibrosing alopecia-A randomized controlled trial.
Rokni GR; Emadi SN; Dabbaghzade A; Jahantigh N; Beyzaee AM; Sharma A; Rudnicka L; Goldust M
J Cosmet Dermatol; 2023 Feb; 22(2):613-619. PubMed ID: 35815916
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of oral pioglitazone in the management of lichen planopilaris in comparison with clobetasol: A randomized clinical trial.
Lajevardi V; Ghiasi M; Balighi K; Daneshpazhooh M; Azar PM; Kianfar N; Dasdar S; Peymanfar AA
Dermatol Ther; 2022 Nov; 35(11):e15868. PubMed ID: 36169160
[TBL] [Abstract][Full Text] [Related]
6. Isotretinoin for the treatment of facial lichen planopilaris: A new indication for an old drug, a case series study.
Fatemi F; Mohaghegh F; Danesh F; Saber M; Rajabi P
Clin Case Rep; 2020 Dec; 8(12):2524-2529. PubMed ID: 33363772
[TBL] [Abstract][Full Text] [Related]
7. The efficacy and safety of oral low dose naltrexone versus placebo in the patients with lichen planopilaris: a randomized controlled clinical trial.
Lajevardi V; Salarvand F; Ghiasi M; Nasimi M; Taraz M
J Dermatolog Treat; 2022 Mar; 33(2):769-773. PubMed ID: 32449418
[TBL] [Abstract][Full Text] [Related]
8. Facial papules of frontal fibrosing alopecia-Response to oral isotretinoin.
Campbell V; McKenna K
Dermatol Ther; 2020 Nov; 33(6):e14274. PubMed ID: 32885907
[No Abstract] [Full Text] [Related]
9. Cyclosporine or methotrexate, which one is more promising in the treatment of lichen planopilaris?; A comparative clinical trial.
Fatemi Naeini F; Mohaghegh F; Jelvan M; Asilian A; Saber M
Int Immunopharmacol; 2020 Sep; 86():106765. PubMed ID: 32674048
[TBL] [Abstract][Full Text] [Related]
10. Facial papules in frontal fibrosing alopecia: evidence of vellus follicle involvement.
Donati A; Molina L; Doche I; Valente NS; Romiti R
Arch Dermatol; 2011 Dec; 147(12):1424-7. PubMed ID: 22184764
[TBL] [Abstract][Full Text] [Related]
11. Lichen Planopilaris Caused by Wig Attachment: A Case of Koebner Phenomenon in Frontal Fibrosing Alopecia.
Taguti P; Dutra H; Trüeb RM
Int J Trichology; 2018; 10(4):172-174. PubMed ID: 30386077
[TBL] [Abstract][Full Text] [Related]
12. Facial Lichen Planopilaris: A Separate Entity or Not? A Case Series.
Van de Maele B; Vossaert K; Lanssens S; Haspeslagh M; De Schepper S
Int J Trichology; 2018; 10(4):183-185. PubMed ID: 30386080
[TBL] [Abstract][Full Text] [Related]
13. Lichen planopilaris in a Latin American (Chilean) population: demographics, clinical profile and treatment experience.
Mardones F; Shapiro J
Clin Exp Dermatol; 2017 Oct; 42(7):755-759. PubMed ID: 28748570
[TBL] [Abstract][Full Text] [Related]
14. A review of isotretinoin in the treatment of frontal fibrosing alopecia.
Shahpar A; Nezhad NZ; Sahaf AS; Ahramiyanpour N
J Cosmet Dermatol; 2024 Jun; 23(6):1956-1963. PubMed ID: 38433314
[TBL] [Abstract][Full Text] [Related]
15. Features of classic lichen planopilaris and frontal fibrosing alopecia in reflectance confocal microscopy: A preliminary study.
Kurzeja M; Czuwara J; Walecka I; Olszewska M; Rudnicka L
Skin Res Technol; 2021 Mar; 27(2):266-271. PubMed ID: 32743819
[TBL] [Abstract][Full Text] [Related]
16. Lichen planopilaris: retrospective study on the characteristics and treatment of 291 patients.
Babahosseini H; Tavakolpour S; Mahmoudi H; Balighi K; Teimourpour A; Ghodsi SZ; Abedini R; Ghandi N; Lajevardi V; Kiani A; Kamyab K; Mohammadi M; Daneshpazhooh M
J Dermatolog Treat; 2019 Sep; 30(6):598-604. PubMed ID: 30411987
[TBL] [Abstract][Full Text] [Related]
17. Lichen planopilaris in men: a retrospective clinicopathologic study of 19 patients.
Cantwell HM; Wieland CN; Proffer SL; Imhof RL; Torgerson RR; Tolkachjov SN
Int J Dermatol; 2021 Apr; 60(4):482-488. PubMed ID: 33128471
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment of rare linear lichen planopilaris with Ixekizumab.
Ahmed H; Petkar M; Steinhoff M
J Dermatolog Treat; 2023 Dec; 34(1):2201364. PubMed ID: 37026832
[No Abstract] [Full Text] [Related]
19. Treatment of frontal fibrosing alopecia and lichen planopilaris: a systematic review.
Rácz E; Gho C; Moorman PW; Noordhoek Hegt V; Neumann HA
J Eur Acad Dermatol Venereol; 2013 Dec; 27(12):1461-70. PubMed ID: 23531029
[TBL] [Abstract][Full Text] [Related]
20. Recalcitrant lichen planopilaris and frontal fibrosing alopecia responding to tildrakizumab.
Trindade de Carvalho L; Meah N; Wall D; Sinclair R
Dermatol Ther; 2020 Jul; 33(4):e13694. PubMed ID: 32458516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
